Cancer Immunology and Immunotherapy

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Specialties, Oncology
Cover of the book Cancer Immunology and Immunotherapy by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642141362
Publisher: Springer Berlin Heidelberg Publication: April 11, 2011
Imprint: Springer Language: English
Author:
ISBN: 9783642141362
Publisher: Springer Berlin Heidelberg
Publication: April 11, 2011
Imprint: Springer
Language: English

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

More books from Springer Berlin Heidelberg

Cover of the book Appetite Control by
Cover of the book Handbuch Mitarbeiterführung by
Cover of the book Didaktik der Bruchrechnung by
Cover of the book Sprache im Fach Mathematik by
Cover of the book Life Cycle Assessment in Industry and Business by
Cover of the book Transactions on Petri Nets and Other Models of Concurrency XI by
Cover of the book Empirical Inference by
Cover of the book Structural Information from Spin-Labels and Intrinsic Paramagnetic Centres in the Biosciences by
Cover of the book Interventional Radiology of the Gallbladder by
Cover of the book Laser Spectroscopy 2 by
Cover of the book Applications of Chaos and Nonlinear Dynamics in Science and Engineering - Vol. 3 by
Cover of the book Pyroclastic Rocks by
Cover of the book Prozessmanagement individuell umgesetzt by
Cover of the book Data Mining in Structural Biology by
Cover of the book National Transport Models by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy